AstraZeneca Computational Pathology GmbH
USPTO PatentsView assignee record - 6 granted patents across 9 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06V (Image OR Video Recognition OR Understanding).
The verdict
According to USPTO PatentsView, Astrazeneca ranks #38,915 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 9 technology areas.
- #38,915
- of 49,997 US assignees by volume
- Top 14%
- by Innovation Score (49.8/100)
- 20.8
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R38915 · Foreign Corporation #38,915 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #38,915/49,997
- PHOTO-FINISH Asoka USA
- CPC-NARROW G06V · 9 areas
- INNOV-PAR 49.8/100
- CLAIMS-DENSE 20.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2024 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Asoka USA Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Astrazeneca’s 49.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Astrazeneca
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- AstraZeneca… · this assignee
AstraZeneca… · this assignee
50 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Astrazeneca's Innovation Score is 49.8/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Astrazeneca?
Each dot is one of Astrazeneca’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Astrazeneca’s own 20.8 claims/patent is ABOVE the 17.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Astrazeneca's grants concentrate
AstraZeneca Computational Pathology GmbH is a focused PatentsView assignee: 9 CPC subclasses with 83.3% of grants classified under G06V (Image OR Video Recognition OR Understanding). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2021. By volume, Astrazeneca sits between Asoka USA Corporation and Atlas Antibodies AB.
Astrazeneca's three-year grant acceleration
AstraZeneca Computational Pathology GmbH shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at AstraZeneca's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Asoka USA
Asoka USA Corporation
6 patents
- Aspects
Aspects, Inc.
6 patents
- Assembled Products
Assembled Products Corporation
6 patents
- Asthmatx
Asthmatx, Inc.
6 patents
- Astral Images
Astral Images Corporation
6 patents
- Athentek Innovati…
Athentek Innovations, Inc.
6 patents
- Atlantis Computing
Atlantis Computing, Inc.
6 patents
- Atlas Antibodies…
Atlas Antibodies AB
6 patents
- Astrazeneca Compu… ◀
AstraZeneca Computational Pathology GmbH
6 patents
What this shows AstraZeneca holds 6 patents at rank #38,957, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near AstraZeneca
By rank, the assignees closest to #38,957 in granted patent volume.
- Asoka USA Corporation #38,953 · 6 patents
- Aspects, Inc. #38,954 · 6 patents
- Assembled Products Corporation #38,955 · 6 patents
- Asthmatx, Inc. #38,956 · 6 patents
- Astral Images Corporation #38,958 · 6 patents
- Athentek Innovations, Inc. #38,959 · 6 patents
- Atlantis Computing, Inc. #38,960 · 6 patents
- Atlas Antibodies AB #38,961 · 6 patents
Leaders in G06V (Image OR Video Recognition OR Understanding)
Other assignees with the most granted patents in AstraZeneca's primary technology class.
- Samsung Electronics Co., Ltd. 3,022 in class
- International Business Machines Corporation 2,565 in class
- Google LLC 1,829 in class
- NEC Corporation 1,631 in class
- Canon Kabushiki Kaisha 1,549 in class
- Microsoft Technology Licensing, LLC 1,310 in class
- Sony Group Corporation 1,287 in class
- Apple Inc. 1,177 in class
Astrazeneca's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
50 Top 14% higher than 86% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 3 | 50.0% |
| 2024 | 1 | 16.7% |
Which technologies does AstraZeneca Computational Pathology GmbH patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
AstraZeneca Computational Pathology GmbH's patent record in context - here's where to go next.
- AstraZeneca Computational Pathology GmbH's lead technology class is G06V (Image OR Video Recognition OR Understanding), 83.3% of its portfolio - see every assignee active in that class. Explore G06V
- Ranked #38,915 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare AstraZeneca Computational Pathology GmbH against Asoka USA Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 49.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.